Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Orbimed Advisors Llc
Form 13F · Q2 2026

Orbimed Advisors Llc

CIK 1055951Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$5.4B
Reported book value
129
Positions
12
Quarters on record
Top 50
Positions

Orbimed Advisors Llc — holdings

Top 50 positions of 129, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1EWTX Edgewise Therapeutics Inc15.5M+0.0%$631M11.7%
2ELVN Enliven Therapeutics Inc6.8M−14.9%$344M6.4%
3LLY Eli Lilly & Co257,900+8.9%$309M5.7%
4MBX Mbx Biosciences Inc3.4M−5.7%$189M3.5%
5SVA Sinovac Biotech Ltd2.7M+0.0%$184M3.4%
6AZN Astrazeneca Plc915,700+36.6%$171M3.2%
7GPCR Structure Therapeutics Inc2.2M+49.7%$119M2.2%
8SION Sionna Therapeutics Inc2.6M−27.6%$112M2.1%
9CRVS Corvus Pharmaceuticals Inc7.2M+0.0%$107M2.0%
10AVBP Arrivent Biopharma Inc3.0M+0.0%$105M1.9%
11GH Guardant Health Inc583,700+34.1%$88M1.6%
12ARGX Argenx Se92,880−32.2%$86M1.6%
13MRK Merck & Co Inc663,400+0.0%$85M1.6%
14UNIQURE NV Uniqure Nv1.8M−15.4%$83M1.5%
15PRAX Praxis Precision Medicines I230,100+33.4%$77M1.4%
16EW Edwards Lifesciences Corp834,900−32.2%$76M1.4%
17PRLD Prelude Therapeutics Inc13.7M+25.8%$73M1.4%
18ABIVAX SA Abivax Sa546,522+17.4%$73M1.3%
19DYN Dyne Therapeutics Inc3.2M+10.9%$72M1.3%
20NTRA Natera Inc262,000+0.0%$71M1.3%
21CGON Cg Oncology Inc972,800+2.6%$69M1.3%
22UNH Unitedhealth Group Inc161,100—$67M1.2%
23SPRY Ars Pharmaceuticals Inc8.3M+0.0%$66M1.2%
24ASND Ascendis Pharma A/S244,456—$65M1.2%
25HUM Humana Inc164,100—$65M1.2%
26COGT Cogent Biosciences Inc1.7M+422.0%$65M1.2%
27BSX Boston Scientific Corp1.5M−37.7%$63M1.2%
28ISRG Intuitive Surgical Inc157,900−24.3%$63M1.2%
29MLYS Mineralys Therapeutics Inc2.1M+2.8%$57M1.1%
30ODTX Odyssey Therapeutics Inc3.0M—$56M1.0%
31XENE Xenon Pharmaceuticals Inc892,471−15.8%$54M1.0%
32ARQT Arcutis Biotherapeutics Inc2.0M—$54M1.0%
33BMY Bristol-Myers Squibb Co925,000+0.0%$53M1.0%
34QTTB Q32 Bio Inc4.1M+83.2%$53M1.0%
35SYK Stryker Corporation159,100−12.8%$50M0.9%
36CAI Caris Life Sciences Inc2.8M+0.0%$50M0.9%
37TMO Thermo Fisher Scientific Inc90,700+95.1%$45M0.8%
38PVLA Palvella Therapeutics Inc Ne292,360+117.2%$45M0.8%
39ELV Elevance Health Inc Formerly114,700+0.0%$44M0.8%
40STTK Shattuck Labs Inc6.3M+0.0%$44M0.8%
41UPB Upstream Bio Inc5.7M+0.0%$39M0.7%
42CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In999,000+0.0%$37M0.7%
43RYTM Rhythm Pharmaceuticals Inc322,900+2.8%$36M0.7%
44SNDX Syndax Pharmaceuticals Inc1.5M+60.2%$34M0.6%
45FORTE BIOSCIENCES INC Forte Biosciences Inc1.6M+31.8%$34M0.6%
46CMPX Compass Therapeutics Inc15.2M+0.0%$33M0.6%
47NKTR Nektar Therapeutics465,346+69.2%$32M0.6%
48KRYS Krystal Biotech Inc83,200+20.4%$31M0.6%
49PHG Koninklijke Philips N V5.7M−8.5%$30M0.6%
50AXSM Axsome Therapeutics Inc.117,578−45.0%$29M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.